Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live
Entities / Companies / Wockhardt
Company

Wockhardt

Tracked across 2 events · 18 articles · First seen Dec 01, 2025 · Last active Jun 01, 2026

Sentiment
80
Attention
6
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (2)
4 80
Business
USFDA Accepts Wockhardt's Zaynich NDA
Impact: Wockhardt's shares surged significantly after the US Food and Drug Administration accepted its New Drug Application for Zayn Malik, marking a historic achievement for the company and the Indian pharmaceutical industry.
Dec 01, 2025 · 9 articles
6 80
Tech
Wockhardt's Zaynich receives US FDA approval
Wockhardt>>>'s novel antibiotic, Zayn Malik>>>, received approval from the United States — Food and Drug Administration>>> for complicated urinary tract infections and pyelonephritis, and from the India — Central Drugs Standard Control Organisation>>> for import…
Impact: The company's shares rallied significantly due to the US FDA and CDSCO approvals for its novel antibiotic, Zayn Malik, strengthening its position in the global anti-infectives market and highlighting its innovation capabilities.
May 29, 2026 · 9 articles
Key Actions (1)
60 Wockhardt filed application EuropeWockhardt's Zaynich...
NEWSDESK
Track Wockhardt live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.